Amesite Announces Partnership with PACE to Deliver Accredited Continuing Education for Healthcare Professionals Using Artificial Intelligence-Driven Platform
- None.
- None.
The partnership between Amesite Inc. and Partners for Advancing Clinical Education (PACE) marks a significant step in the evolution of continuing education for healthcare professionals. The integration of Amesite's AI-powered platform with PACE's accredited programs addresses a critical need for scalable and accessible professional development in the healthcare sector. This collaboration is poised to enhance the quality and delivery of continuing education, which is essential for maintaining professional competencies and meeting licensure requirements.
The demand for continuing education in healthcare is driven by rapid advancements in medical knowledge and technology. As such, the ability to offer accredited CE credits across various healthcare fields through an AI-driven platform can lead to improved educational outcomes and more efficient knowledge dissemination. This initiative could also have a positive impact on patient care by ensuring that healthcare professionals remain current with the latest practices and innovations.
From an industry perspective, the collaboration between Amesite and PACE could signal a broader trend towards the adoption of technology in professional healthcare education. Amesite's entry into the market as a Joint Provider of accredited continuing education programs has the potential to disrupt traditional CE delivery models. This move may prompt competitive responses from other players in the medical education space, ultimately benefiting healthcare professionals through more diverse and advanced learning options.
Furthermore, the scalability of AI-powered solutions like Amesite's could lead to cost efficiencies and wider reach, potentially making high-quality education more affordable and accessible to healthcare professionals nationwide. This could translate into a competitive advantage for Amesite and contribute to its market share growth, which may be of interest to investors monitoring the education technology sector.
The strategic partnership announcement is likely to be viewed favorably by investors, as it opens up a significant recurring revenue stream for Amesite. The healthcare education market is substantial, with over eighteen million professionals requiring ongoing CE. By tapping into this market, Amesite diversifies its revenue base and strengthens its position within the education technology industry.
Investors should also consider the long-term implications of Amesite's AI-driven platform in terms of scalability and potential to penetrate other professional education markets. The success of this partnership could serve as a proof of concept, encouraging expansion into additional sectors that require accredited professional development. This scalability factor, coupled with the high integrity and accreditation standards of PACE, could make Amesite an attractive proposition for stakeholders interested in the intersection of technology and professional education.
DETROIT, March 04, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announces today it is collaborating with Partners for Advancing Clinical Education (PACE) to deliver accredited continuing education for healthcare professionals on Amesite’s AI-powered platform.
In support of patient care, PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. An Accredited Provider respected for its collaborative community of leading educators, PACE is dedicated to the development and delivery of high-integrity, accredited continuing education programs.
Pursuant to the terms of the partnership, Amesite, as a Joint Provider, is now able to jointly develop and deliver accredited continuing education (CE) programs that may be presented to learners, awarding CE credits in numerous healthcare fields.
Dr. Ann Marie Sastry, CEO of Amesite, commented, "Securing Joint Providership enables us to deliver to a market that has a strong, recurring need for continuing professional development training. With over eighteen million healthcare professionals nationwide, the need for accessible, high-quality CE has never been greater. Amesite's AI-driven solution is designed to meet this demand, ensuring that professionals have the resources they need to advance their skills and continue providing exceptional care."
Michael Lemon, President of PACE, stated, "We are thrilled to welcome Amesite as a Partner. Their technology-driven approach to education represents a significant addition to the market, especially at a time when the demand for continuing education is expanding rapidly. Amesite's innovative use of AI in education aligns perfectly with our drive to deliver meaningful learning experiences that adhere to the highest standards of educational integrity and accreditation."
About Amesite Inc.
Amesite is an ed-tech, SaaS company with the most advanced artificial intelligence driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multi-billion-dollar online learning markets in business and education. For more information, visit https://amesite.com.
Forward Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact:
MJ Clyburn
TraDigital IR
clyburn@tradigitalir.com
FAQ
What is the collaboration between Amesite Inc. and PACE about?
What accreditation does PACE have?
Who is Dr. Ann Marie Sastry and what is her role at Amesite?
What does Michael Lemon, President of PACE, think about Amesite's technology?
